You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsing

Showing 1 - 25 of 2,409
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Relapsing Polychondritis : Diagnosis and Management

Recruiting
  • Relapsing Polychondritis
    • Strasbourg, France
      Service de Pédiatrie 1 - CHU de Strasbourg - France
    Aug 24, 2023

    Relapsing Fever, Tick-Borne Trial (administration of single dose of doxycycline)

    Not yet recruiting
    • Relapsing Fever, Tick-Borne
    • administration of single dose of doxycycline
    • (no location specified)
    Sep 21, 2023

    Relapsing Multiple Sclerosis, Multiple Sclerosis Trial (Placebo, Pirtobrutinib)

    Not yet recruiting
    • Relapsing Multiple Sclerosis
    • Multiple Sclerosis
    • (no location specified)
    Oct 24, 2023

    Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

    Not yet recruiting
    • Relapsing Remitting Multiple Sclerosis
    • PIPE-307 Dose A
    • +2 more
    • (no location specified)
    Oct 9, 2023

    Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

    Not yet recruiting
    • Relapsing-remitting Multiple Sclerosis
    • CT-P53
    • +2 more
    • (no location specified)
    Jun 7, 2023

    Assess New Participant's Perspectives Beyond Clinical Efficacy

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
      • (no location specified)
      Nov 7, 2023

      Multiple Sclerosis Trial in Montpellier (Magnetic Resonance Imaging, Blood withdrawal, Neuropsychological tests)

      Not yet recruiting
      • Multiple Sclerosis
      • Magnetic Resonance Imaging
      • +2 more
      • Montpellier, France
        Neurology Department, Hopital Gui de Chauliac
      Jul 18, 2023

      Multiple Sclerosis, Relapsing-Remitting Trial in Elazig (Reiki)

      Recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • Reiki
      • Elazıg, Turkey
        Firat University
      Nov 8, 2023

      Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

      Not yet recruiting
      • Relapsing-remitting Multiple Sclerosis (RRMS)
        • (no location specified)
        Apr 11, 2023

        Multiple Sclerosis Trial in Genova (7-day Fasting-Mimicking Diet (7-DAY FMD))

        Active, not recruiting
        • Multiple Sclerosis
        • 7-day Fasting-Mimicking Diet (7-DAY FMD)
        • Genova, Italy
          Ospedale San Martino
        Sep 8, 2023

        Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

        Recruiting
        • Multiple Sclerosis
        • +5 more
        • Amsterdam, Netherlands
          Amsterdam UMC, location VUmc
        Apr 17, 2023

        Describe Switching FromFirst- or Second-line Disease Modifying

        Not yet recruiting
        • Multiple Sclerosis, Relapsing-Remitting
          • (no location specified)
          Dec 12, 2022

          Nephrotic Syndrome in Children, Telitacicept Trial in Hangzhou (Telitacicept)

          Recruiting
          • Nephrotic Syndrome in Children
          • Telitacicept
          • Hangzhou, Zhejiang, China
            Children's Hospital, Zhejiang University School of Medicine
          Nov 8, 2023

          Multiple Sclerosis, Relapsing-Remitting Trial in Munich, Mainz, Münster (Vivomixx®, Conjugated linoleic acid (CLA/Tonalin® FFA

          Not yet recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • Vivomixx®
          • +3 more
          • Munich, Bavaria, Germany
          • +2 more
          Jun 15, 2023

          Longitudinal Study for Relapsing Polychondritis

          Recruiting
          • Relapsing Polychondritis
          • Vasculitis
            • Philadelphia, Pennsylvania
              University of Pennsylvania
            Jul 11, 2022

            Multiple Sclerosis, Relapsing-Remitting, Fatigue Trial (TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY], Placebo)

            Withdrawn
            • Multiple Sclerosis, Relapsing-Remitting
            • Fatigue
            • TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]
            • Placebo
            • Boston, Massachusetts
              Massachusetts General Hospital
            Nov 14, 2022

            Ampullary Carcinoma Trial (Surufatinib+Toripalimab+AG)

            Not yet recruiting
            • Ampullary Carcinoma
            • (no location specified)
            Sep 29, 2023

            Relapsing Forms of Multiple Sclerosis Trial (BIIB091, DRF, Placebo)

            Not yet recruiting
            • Relapsing Forms of Multiple Sclerosis
            • (no location specified)
            Mar 23, 2023

            Multiple Sclerosis Trial (Frexalimab, Teriflunomide, Placebo infusion)

            Not yet recruiting
            • Multiple Sclerosis
            • (no location specified)
            Nov 15, 2023

            Ocrelizumab and Ofatumumab Administration in Relapsing Multiple

            Completed
            • Relapsing Forms of Multiple Sclerosis
            • Lutherville, Maryland
            • +1 more
            Oct 19, 2022

            Bafiertam Treatment In Routine Clinical Practice

            Enrolling by invitation
            • Relapsing Remitting Multiple Sclerosis
            • Monomethyl Fumarate
            • West Hollywood, California
            • +1 more
            Aug 3, 2023

            Steroid Dependent and Frequent Relapsing Nephrotic Syndrome in

            Not yet recruiting
            • Steroid Dependent and Frequent Relapsing Nephrotic Syndrome
            • observation of the adverse outcomes of Cyclosporine in steroid dependent and frequent relapsing nephrotic syndrome in children
            • Sohag, Egypt
              Sohag University Hospital
            Oct 17, 2022

            Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)

            Active, not recruiting
            • Multiple Sclerosis, Relapsing-Remitting
            • Multiple Sclerosis, Secondary Progressive
            • Tokyo, Japan
              National Center of Neurology and Psychiatry
            Sep 28, 2022

            Multiple Sclerosis, Relapsing-Remitting Trial in La Jolla (Autologous hematopoietic stem cell transplantation,

            Recruiting
            • Multiple Sclerosis, Relapsing-Remitting
            • Autologous hematopoietic stem cell transplantation
            • +2 more
            • La Jolla, California
              Scripps Green Hospital
            Aug 16, 2022

            Lesion Load and Location in Relation to Cognition, Fatigue and

            Completed
            • Relapsing Remitting Multiple Sclerosis
            • VolBrain, a fully automated platform to generate the volumetric data (lesion count, volume and location as well as different atrophy measures)
            • Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
            • Assiut, Egypt
              Eman Khedr
            Oct 27, 2022